Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by Mayleben Timothy M, Directeur. Insider active across 3 companies, notably Marinus Pharmaceuticals INC. Aggregated, 8 filings have been published. Split: 2 buys · 0 sell. History available since 4 February 2022. The latest transaction was disclosed on 7 February 2025 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Directeur, MAYLEBEN TIMOTHY M has 8 filings in total. Across the 8 sampled filings, the period runs from 2016-01-19 to 2025-02-11, with EUR 0 of buys and EUR 2436 of sells, and the most frequent transaction nature is Attribution.